VIR – vir biotechnology, inc. (US:NASDAQ)
Stock Stats
News
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta
Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results [Yahoo! Finance]
Vir Biotechnology, Inc. (NASDAQ: VIR) had its price target raised by analysts at Barclays PLC from $26.00 to $31.00. They now have an "overweight" rating on the stock.
Form 4 Vir Biotechnology, Inc. For: Apr 03 Filed by: De Backer Marianne
Form 144 Vir Biotechnology, Inc. Filed by: De Backer Marianne
Form 4 Vir Biotechnology, Inc. For: Feb 26 Filed by: de Verneuil Vanina
Form S-8 Vir Biotechnology, Inc.
Form 10-K Vir Biotechnology, Inc. For: Dec 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.